Healthcare
Live Price
Offline$0.92
+3.25% today
1Y Change
-34.75%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
RenovoRx, Inc. (RNXT) is a Healthcare stock with a market cap of $30.00M and listed on NASDAQ. The stock last traded around $0.92 and down 34.8% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +2511.6%, EPS growth of +13.5%, a dividend yield of 0.0%. What stands out right now is revenue +2511.6%, EPS +13.5%, free cash flow -20.1% with operating margin -1114.0% and ROIC -204.0%. Valuation already assumes a fairly strong business story at price/sales 27.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines RNXT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RNXT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RNXT Max Drawdown
-48.38%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RNXT and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.